CoChat
Sign Up
Cited by 334

TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets

Scotter, Emma L., Chen, Han-Jou, Shaw, Christopher E.·2015·Neurotherapeutics
DOI 10.1007/s13311-015-0338-xPMC PMC4404432
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s13311-015-0338-x

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Patients with traumatic brain injuries have been found to have an overexpression of TDP-43, which contributes to the neurocognitive dysfunction seen in these patients.

    “Patients with traumatic brain injuries have been found to have an overexpression of this protein, which contributes to the neurocognitive dysfunction seen in these patients [46,47,48].”

    From Head Injury and Amyotrophic Lateral Sclerosis: Population-Based Study from the National ALS Registry (2025) · cites this paper as [48]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 161

  1. [1]Neumann M Sampathu DM Kwong LK Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Science 2006 314 130 133 17023659
  2. [3]Arai T Hasegawa M Akiyama H TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Biochem Biophys Res Commun 2006 351 602 611 17084815
  3. [4]Ou SH Wu F Harrich D Garcia-Martinez LF Gaynor RB Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs J Virol 1995 69 3584 3596 7745706 PMC189073
  4. [5]Winton MJ Igaz LM Wong MM Kwong LK Trojanowski JQ Lee VM-Y Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation J Biol Chem 2008 283 13302 13309 18305110 PMC2442318
  5. [6]Buratti E Brindisi A Giombi M Tisminetzky S Ayala YM Baralle FE TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing J Biol Chem 2005 280 37572 37584 16157593
  6. [7]Hebron ML Lonskaya I Sharpe K Parkin ubiquitinates Tar-DNA binding protein-43 (TDP-43) and promotes its cytosolic accumulation via interaction with histone deacetylase 6 (HDAC6) J Biol Chem 2013 288 4103 4115 23258539 PMC3567661
  7. [8]Gregory RI Yan K-p Amuthan G The microprocessor complex mediates the genesis of microRNAs Nature 2004 432 235 240 15531877
  8. [9]Xu ZS Does a loss of TDP-43 function cause neurodegeneration? Mol Neurodegener 2012 7 27 22697423 PMC3419078
  9. [11]Ayala YM De Conti L Avendano-Vazquez SE TDP-43 regulates its mRNA levels through a negative feedback loop EMBO J 2011 30 277 288 21131904 PMC3025456
  10. [12]Tollervey JR Curk T Rogelj B Characterizing the RNA targets and position-dependent splicing regulation by TDP-43 Nat Neurosci 2011 14 452 458 21358640 PMC3108889
  11. [13]Carlomagno Y Zhang Y Davis M Casein kinase II induced polymerization of soluble TDP-43 into filaments is inhibited by heat shock proteins PLoS One 2014 9 e90452 24595055 PMC3942448
  12. [15]Bose JK Huang CC Shen CK Regulation of autophagy by neuropathological protein TDP-43 J Biol Chem 2011 286 44441 44448 22052911 PMC3247982
  13. [16]Barmada SJ Skibinski G Korb E Rao EJ Wu JY Finkbeiner S Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis J Neurosci 2010 30 639 649 20071528 PMC2821110
  14. [17]Diaper DC Adachi Y Sutcliffe B Loss and gain of Drosophila TDP-43 impair synaptic efficacy and motor control leading to age-related neurodegeneration by loss-of-function phenotypes Hum Mol Genet 2013 22 1539 1557 23307927 PMC3605831
  15. [18]Alami NH Smith RB Carrasco MA Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations Neuron 2014 81 536 543 24507191 PMC3939050
  16. [19]Liu-Yesucevitz L Lin AY Ebata A ALS-linked mutations enlarge TDP-43-enriched neuronal RNA granules in the dendritic arbor J Neurosci 2014 34 4167 4174 24647938 PMC3960463
  17. [20]Colombrita C Zennaro E Fallini C TDP-43 is recruited to stress granules in conditions of oxidative insult J Neurochem 2009 111 1051 1061 19765185
  18. [21]Lindquist S Regulation of protein synthesis during heat shock Nature 1981 293 311 314 6792546
  19. [22]Mackenzie IR Bigio EH Ince PG Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations Ann Neurol 2007 61 427 434 17469116
  20. [23]Maekawa S Leigh PN King A TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations Neuropathology 2009 29 672 683 19496940
  21. [24]Mackenzie IRA Bigio EH Ince PG Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations Ann Neurol 2007 61 427 434 17469116
  22. [25]Tan CF Eguchi H Tagawa A TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation Acta Neuropathol 2007 113 535 542 17333220
  23. [26]Tateishi T Hokonohara T Yamasaki R Multiple system degeneration with basophilic inclusions in Japanese ALS patients with FUS mutation Acta Neuropathol 2010 119 355 364 19967541
  24. [27]Vance C Rogelj B Hortobagyi T Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6 Science 2009 323 1208 1211 19251628 PMC4516382
  25. [28]Suzuki N Aoki M Warita H FALS with FUS mutation in Japan, with early onset, rapid progress and basophilic inclusion J Hum Genet 2010 55 252 254 20224596
  26. [29]Kwong LK Neumann M Sampathu DM Lee VM Trojanowski JQ TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease Acta Neuropathol 2007 114 63 70 17492294
  27. [30]Brettschneider J Del Tredici K Toledo JB Stages of pTDP-43 pathology in amyotrophic lateral sclerosis Ann Neurol 2013 74 20 38 23686809 PMC3785076
  28. [31]Wils H Kleinberger G Janssens J TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration Proc Natl Acad Sci U S A 2010 107 3858 3863 20133711 PMC2840518
  29. [32]Li Y Ray P Rao EJ A Drosophila model for TDP-43 proteinopathy Proc Natl Acad Sci U S A 2010 107 3169 3174 20133767 PMC2840283
  30. [33]Ash PE Zhang YJ Roberts CM Neurotoxic effects of TDP-43 overexpression in C. elegans Hum Mol Genet 2010 19 3206 3218 20530643 PMC2908471
  31. [34]Wu LS Cheng WC Hou SC Yan YT Jiang ST Shen CK TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis Genesis 2010 48 56 62 20014337
  32. [37]Wu LS Cheng WC Shen CK Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice J Biol Chem 2012 287 27335 27344 22718760 PMC3431639
  33. [38]Iguchi Y Katsuno M Niwa J Loss of TDP-43 causes age-dependent progressive motor neuron degeneration Brain 2013 136 1371 1382 23449777
  34. [39]Kabashi E Lin L Tradewell ML Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo Hum Mol Genet 2010 19 671 683 19959528
  35. [40]Yang C Wang H Qiao T Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis Proc Natl Acad Sci U S A 2014 111 E1121 E1129 24616503 PMC3970502
  36. [41]Diaper DC Adachi Y Lazarou L Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD Hum Mol Genet 2013 22 3883 3893 23727833 PMC3766182
  37. [42]Renton AE Chio A Traynor BJ State of play in amyotrophic lateral sclerosis genetics Nat Neurosci 2014 17 17 23 24369373 PMC4544832
  38. [43]Sreedharan J Blair IP Tripathi VB TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis Science 2008 319 1668 1672 18309045 PMC7116650
  39. [44]Van Deerlin VM Leverenz JB Bekris LM TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis Lancet Neurol 2008 7 409 416 18396105 PMC3546119
  40. [45]Rutherford NJ Zhang YJ Baker M Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis PLoS Genet 2008 4 e1000193 18802454 PMC2527686
  41. [46]Kabashi E Valdmanis PN Dion P TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis Nat Genet 2008 40 572 574 18372902
  42. [47]Abel O Powell JF Andersen PM Al-Chalabi A ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics Hum Mutat 2012 33 1345 1351 22753137
  43. [48]Corrado L Ratti A Gellera C High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis Hum Mutat 2009 30 688 694 19224587
  44. [49]Kirby J Goodall EF Smith W Broad clinical phenotypes associated with TAR-DNA binding protein (TARDBP) mutations in amyotrophic lateral sclerosis Neurogenetics 2010 11 217 225 19760257
  45. [50]Xiong HL Wang JY Sun YM Association between novel TARDBP mutations and Chinese patients with amyotrophic lateral sclerosis BMC Med Genet 2010 11 8 20082726 PMC2821387
  46. [51]Zou ZY Peng Y Wang XN Liu MS Li XG Cui LY Screening of the TARDBP gene in familial and sporadic amyotrophic lateral sclerosis patients of Chinese origin Neurobiol Aging 2012 33 2229 e11 e18 22575358
  47. [52]Del Bo R Ghezzi S Corti S TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations Eur J Neurol 2009 16 727 732 19236453
  48. [53]Lemmens R Race V Hersmus N TDP-43 M311V mutation in familial amyotrophic lateral sclerosis J Neurol Neurosurg Psychiatry 2009 80 354 355 19228676
  49. [54]Baumer D Parkinson N Talbot K TARDBP in amyotrophic lateral sclerosis: identification of a novel variant but absence of copy number variation J Neurol Neurosurg Psychiatry 2009 80 1283 1285 19864663
  50. [56]Kuhnlein P Sperfeld AD Vanmassenhove B Two German kindreds with familial amyotrophic lateral sclerosis due to TARDBP mutations Arch Neurol 2008 65 1185 1189 18779421 PMC2742976
  51. [57]Daoud H Valdmanis PN Kabashi E Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis J Med Genet 2009 46 112 114 18931000
  52. [58]Origone P Caponnetto C Bandettini Di Poggio M Enlarging clinical spectrum of FALS with TARDBP gene mutations: S393L variant in an Italian family showing phenotypic variability and relevance for genetic counselling Amyotroph Lateral Scler 2010 11 223 227 19714537
  53. [59]Arnold ES Ling SC Huelga SC ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43 Proc Natl Acad Sci U S A 2013 110 E736 E745 23382207 PMC3581922
  54. [61]Serio A Bilican B Barmada SJ Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy Proc Natl Acad Sci U S A 2013 110 4697 4702 23401527 PMC3607024
  55. [62]Han JH Yu TH Ryu HH ALS/FTLD-linked TDP-43 regulates neurite morphology and cell survival in differentiated neurons Exp Cell Res 2013 319 1998 2005 23742895
  56. [63]Nonaka T Kametani F Arai T Akiyama H Hasegawa M Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43 Hum Mol Genet 2009 18 3353 3364 19515851
  57. [64]Johnson BS Snead D Lee JJ McCaffery JM Shorter J Gitler AD TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity J Biol Chem 2009 284 20329 20339 19465477 PMC2740458
  58. [65]Budini M Romano V Avendano-Vazquez SE Bembich S Buratti E Baralle FE Role of selected mutations in the Q/N rich region of TDP-43 in EGFP-12xQ/N-induced aggregate formation Brain Res 2012 1462 139 150 22406069
  59. [66]Barmada SJ Serio A Arjun A Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models Nat Chem Biol 2014 10 677 685 24974230 PMC4106236
  60. [67]Ling SC Albuquerque CP Han JS ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS Proc Natl Acad Sci U S A 2010 107 13318 13323 20624952 PMC2922163
  61. [68]Watanabe S Kaneko K Yamanaka K Accelerated disease onset with stabilized familial amyotrophic lateral sclerosis (ALS)-linked mutant TDP-43 proteins J Biol Chem 2013 288 3641 3654 23235148 PMC3561582
  62. [69]Wu LS Cheng WC Shen CK Similar dose-dependence of motor neuron cell death caused by wild type human TDP-43 and mutants with ALS-associated amino acid substitutions J Biomed Sci 2013 20 33 23721326 PMC3684520
  63. [70]Nishimura AL Shum C Scotter EL Allele-specific knockdown of ALS-associated mutant TDP-43 in neural stem cells derived from induced pluripotent stem cells PLoS One. 2014 9 e91269 24651281 PMC3961241
  64. [71]Miller TM Pestronk A David W An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study Lancet Neurol 2013 12 435 442 23541756 PMC3712285
  65. [72]Fecto F Yan J Vemula SP SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis Arch Neurol 2012 68 1440 1446 22084127
  66. [73]Watts GD Wymer J Kovach MJ Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein Nat Genet 2004 36 377 381 15034582
  67. [74]Deng HX Chen W Hong ST Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia Nature 2011 477 211 215 21857683 PMC3169705
  68. [75]Maruyama H Morino H Ito H Mutations of optineurin in amyotrophic lateral sclerosis Nature 2010 465 223 226 20428114
  69. [76]Ju JS Fuentealba RA Miller SE Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease J Cell Biol 2009 187 875 888 20008565 PMC2806317
  70. [78]Seibenhener ML Babu JR Geetha T Wong HC Krishna NR Wooten MW Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation Mol Cell Biol 2004 24 8055 8068 15340068 PMC515032
  71. [80]Kleijnen MF Shih AH Zhou P The hPLIC Proteins may provide a link between the ubiquitination machinery and the proteasome Mol Cell 2000 6 409 419 10983987
  72. [82]Wild P Farhan H McEwan DG Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth Science 2011 333 228 233 21617041 PMC3714538
  73. [83]Scotter EL Vance C Nishimura AL Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species J Cell Sci 2014 127 1263 1278 24424030 PMC3953816
  74. [84]Caccamo A Majumder S Deng JJ Bai Y Thornton FB Oddo S Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability J Biol Chem 2009 284 27416 27424 19651785 PMC2785671
  75. [85]Urushitani M Sato T Bamba H Hisa Y Tooyama I Synergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP-43 J Neurosci Res 2010 88 784 797 19798749
  76. [86]Wang X Fan H Ying Z Li B Wang H Wang G Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system Neurosci Lett 2010 469 112 116 19944744
  77. [87]Zhang YJ Xu YF Cook C Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity Proc Natl Acad Sci U S A 2009 106 7607 7612 19383787 PMC2671323
  78. [88]Wojcik C Yano M DeMartino GN RNA interference of valosin-containing protein (VCP/p97) reveals multiple cellular roles linked to ubiquitin/proteasome-dependent proteolysis J Cell Sci 2004 117 281 292 14657277
  79. [89]Lamark T Johansen T Autophagy: links with the proteasome Curr Opin Cell Biol 2009 22 192 198 19962293
  80. [90]Thomas M Alegre-Abarrategui J Wade-Martins R RNA dysfunction and aggrephagy at the centre of an amyotrophic lateral sclerosis/frontotemporal dementia disease continuum Brain 2013 136 1345 1360 23474849
  81. [91]Lamark T Johansen T Aggrephagy: selective disposal of protein aggregates by macroautophagy Int J Cell Biol 2012 2012 736905 22518139 PMC3320095
  82. [92]Kopito RR Aggresomes, inclusion bodies and protein aggregation Trends Cell Biol 2000 10 524 530 11121744
  83. [93]Colby DW Cassady JP Lin GC Ingram VM Wittrup KD Stochastic kinetics of intracellular huntingtin aggregate formation Nat Chem Biol 2006 2 319 323 16699519
  84. [94]Jarrett JT Lansbury PT Jr Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 1993 73 1055 1058 8513491
  85. [95]Wood SJ Wypych J Steavenson S Louis J-C Citron M Biere AL α-Synuclein fibrillogenesis is nucleation-dependent: Implications for the pathogenesis of Parkinsonatidisease J Biol Chem 1999 274 19509 19512 10391881
  86. [96]King OD Gitler AD Shorter J The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease Brain Res 2012 1462 61 80 22445064 PMC3372647
  87. [97]Johnson JO Mandrioli J Benatar M Exome sequencing reveals VCP mutations as a cause of familial ALS Neuron 2010 68 857 864 21145000 PMC3032425
  88. [98]Lee BH Lee MJ Park S Enhancement of proteasome activity by a small-molecule inhibitor of USP14 Nature 2010 467 179 184 20829789 PMC2939003
  89. [99]Wang IF Guo BS Liu YC Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43 Proc Natl Acad Sci U S A 2012 109 15024 15029 22932872 PMC3443184
  90. [100]Lagier-Tourenne C Polymenidou M Hutt KR Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs Nat Neurosci 2012 15 1488 1497 23023293 PMC3586380
  91. [101]Honda D Ishigaki S Iguchi Y The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons FEBS Open Bio 2013 4 1 10 24319651 PMC3851184
  92. [104]Lee YB Chen HJ Peres JN Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic Cell Rep 2013 5 1178 1186 24290757 PMC3898469
  93. [105]Cooper-Knock J Walsh MJ Higginbottom A Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions Brain 2014 137 2040 2051 24866055 PMC4065024
  94. [106]Lagier-Tourenne C Baughn M Rigo F Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration Proc Natl Acad Sci U S A 2013 110 E4530 E4539 24170860 PMC3839752
  95. [107]Donnelly CJ Zhang PW Pham JT RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention Neuron 2013 80 415 428 24139042 PMC4098943
  96. [108]Troakes C Maekawa S Wijesekera L An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline Neuropathology 2012 32 505 514 22181065
  97. [109]Brettschneider J Van Deerlin VM Robinson JL Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion Acta Neuropathol 2012 123 825 839 22426854 PMC3521561
  98. [110]Mann DM Rollinson S Robinson A Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72 Acta Neuropathol Commun 2013 1 68 24252525 PMC3893586
  99. [111]Ash PE Bieniek KF Gendron TF Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS Neuron 2013 77 639 646 23415312 PMC3593233
  100. [112]Mori K Weng SM Arzberger T The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS Science 2013 339 1335 1338 23393093
  101. [113]Kwon I Xiang S Kato M Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells Science 2014 345 1139 1145 25081482 PMC4459787
  102. [115]Yamakawa M, Ito D, Honda T, et al. Characterization of the dipeptide repeat protein in the molecular pathogenesis of c9FTD/ALS. Hum Mol Genet 2014 Nov 14 [Epub ahead of print]. 25398948
  103. [116]May S Hornburg D Schludi MH C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration Acta Neuropathol 2014 128 485 503 25120191 PMC4159571
  104. [117]Davidson YS Barker H Robinson AC Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72 Acta Neuropathol Commun 2014 2 70 24950788 PMC4229740
  105. [119]Su Z Zhang Y Gendron TF Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS Neuron 2014 83 1043 1050 25132468 PMC4232217
  106. [120]Zamiri B Reddy K Macgregor RB Jr Pearson CE TMPyP4 porphyrin distorts RNA G-quadruplex structures of the disease-associated r(GGGGCC)n repeat of the C9orf72 gene and blocks interaction of RNA-binding proteins J Biol Chem 2014 289 4653 4659 24371143 PMC3931028
  107. [121]Johnson JO Pioro EP Boehringer A Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis Nat Neurosci 2014 17 664 666 24686783 PMC4000579
  108. [122]Kim HJ Kim NC Wang YD Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS Nature 2013 495 467 473 23455423 PMC3756911
  109. [123]Kusui K Epidemiological study on amyotrophic lateral sclerosis (ALS) and other neighboring motor neuron diseases in Kii Peninsula Seishin Shinkeigaku Zasshi 1962 64 85 99 14460927
  110. [124]Huang CC Bose JK Majumder P Metabolism and mis-metabolism of the neuropathological signature protein TDP-43 J Cell Sci 2014 127 3024 3038 24860144
  111. [125]Ishiura H Takahashi Y Mitsui J C9ORF72 repeat expansion in amyotrophic lateral sclerosis in the Kii peninsula of Japan Arch Neurol 2012 69 1154 1158 22637429
  112. [126]Smith Bradley N Ticozzi N Fallini C Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS Neuron 2014 84 324 331 25374358 PMC4521390
  113. [127]Smith BN, Vance C, Scotter EL, et al. Novel mutations support a role for Profilin1 in the pathogenesis of ALS. Neurobiol Aging 2014 Oct 31 [Epub ahead of print]. PMC4357530 25499087
  114. [128]Sieh W Choi Y Chapman NH Identification of novel susceptibility loci for Guam neurodegenerative disease: challenges of genome scans in genetic isolates Hum Mol Genet 2009 18 3725 3738 19567404 PMC2742398
  115. [129]Jansson D Rustenhoven J Feng S A role for human brain pericytes in neuroinflammation J Neuroinflammation 2014 11 104 24920309 PMC4105169
  116. [130]Synofzik M Born C Rominger A Targeted high-throughput sequencing identifies a TARDBP mutation as a cause of early-onset FTD without motor neuron disease Neurobiol Aging 2014 35 1212 e1 5 24300238
  117. [131]Johnson RT, Bradley W, Ritz B, Rocca WA, Shefner J, Wolfson C. Amyotrophic lateral sclerosis in veterans: Review of the scientific literature. United States of America: The National Academies Press, 2006, Report No.: 9780309102544.
  118. [132]Mizielinska S Lashley T Norona FE C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci Acta Neuropathol 2013 126 845 857 24170096 PMC3830745
  119. [134]Orrell RW Lane RJ Ross M A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease Amyotroph Lateral Scler 2008 9 195 211 18608090
  120. [135]Polling S Mok YF Ramdzan YM Misfolded polyglutamine, polyalanine, and superoxide dismutase 1 aggregate via distinct pathways in the cell J Biol Chem 2014 289 6669 6680 24425868 PMC3945328
  121. [136]Dewey CM, Cenik B, Sephton CF, et al. TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol Cell Biol 2010:MCB.01279-10. PMC3067820 21173160
  122. [137]Liu-Yesucevitz L Bilgutay A Zhang YJ Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue PLoS One 2010 5 e13250 20948999 PMC2952586
  123. [138]McDonald KK Aulas A Destroismaisons L TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1 Hum Mol Genet 2011 20 1400 1410 21257637
  124. [139]Udan-Johns M Bengoechea R Bell S Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40/70 chaperones Hum Mol Genet 2014 23 157 170 23962724 PMC3857952
  125. [140]Dormann D Haass C TDP-43 and FUS: a nuclear affair Trends Neurosci 2011 34 339 348 21700347
  126. [141]Kim HJ Raphael AR LaDow ES Therapeutic modulation of eIF2alpha phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models Nat Genet 2014 46 152 160 24336168 PMC3934366
  127. [142]Meyerowitz J Parker SJ Vella LJ C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress Mol Neurodegener 2011 6 57 21819629 PMC3162576
  128. [143]Bentmann E Neumann M Tahirovic S Rodde R Dormann D Haass C Requirements for stress granule recruitment of fused in Sarcoma (FUS) and TAR DNA binding protein of 43 kDa (TDP-43) J Biol Chem 2012 287 23079 23094 22563080 PMC3391091
  129. [144]Dormann D Rodde R Edbauer D ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import EMBO J 2010 29 2841 2857 20606625 PMC2924641
  130. [145]Zhou H Huang C Chen H Transgenic rat model of neurodegeneration caused by mutation in the TDP gene PLoS Genet 2010 6 e1000887 20361056 PMC2845661
  131. [146]De Marco G Lupino E Calvo A Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations Acta Neuropathol 2011 121 611 622 21120508
  132. [148]Igaz LM Kwong LK Lee EB Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice J Clin Invest 2011 121 726 738 21206091 PMC3026736
  133. [149]Igaz LM Kwong LK Xu Y Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis Am J Pathol 2008 173 182 194 18535185 PMC2438296
  134. [150]Suzuki H Lee K Matsuoka M TDP-43-induced death is associated with altered regulation of BIM and Bcl-xL and attenuated by caspase-mediated TDP-43 cleavage J Biol Chem 2011 286 13171 13183 21339291 PMC3075664
  135. [151]Dormann D Capell A Carlson AM Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulin J Neurochem 2009 110 1082 1094 19522733
  136. [152]Zhang YJ Xu YF Dickey CA Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43 J Neurosci 2007 27 10530 10534 17898224 PMC6673167
  137. [153]Fuentealba RA Udan M Bell S Interaction with polyglutamine aggregates reveals a Q/N-rich domain in TDP-43 J Biol Chem 2010 285 26304 26314 20554523 PMC2924052
  138. [154]Furukawa Y Kaneko K Nukina N Molecular properties of TAR DNA binding protein-43 fragments are dependent upon its cleavage site Biochim Biophys Acta 1812 2011 1577 1583 21946215
  139. [155]Yang C Tan W Whittle C The C-terminal TDP-43 fragments have a high aggregation propensity and harm neurons by a dominant-negative mechanism PLoS One 2010 5 e15878 21209826 PMC3013128
  140. [156]Che MX Jiang YJ Xie YY Jiang LL Hu HY Aggregation of the 35-kDa fragment of TDP-43 causes formation of cytoplasmic inclusions and alteration of RNA processing FASEB J 2011 25 2344 2353 21450909
  141. [157]Voigt A Herholz D Fiesel FC TDP-43-mediated neuron loss in vivo requires RNA-binding activity PLoS One 2010 5 e12247 20806063 PMC2923622
  142. [158]Pesiridis GS Tripathy K Tanik S Trojanowski JQ Lee VM A "two-hit" hypothesis for inclusion formation by carboxyl-terminal fragments of TDP-43 protein linked to RNA depletion and impaired microtubule-dependent transport J Biol Chem 2011 286 18845 18855 21454607 PMC3099701
  143. [159]Van Langenhove T van der Zee J Van Broeckhoven C The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum Ann Med 2012 44 817 828 22420316 PMC3529157
  144. [160]Tsuiji H Iguchi Y Furuya A Spliceosome integrity is defective in the motor neuron diseases ALS and SMA EMBO Mol Med 2013 5 221 234 23255347 PMC3569639
  145. [161]Jackrel ME DeSantis ME Martinez BA Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events Cell 2014 156 170 182 24439375 PMC3909490
  146. [162]Gregory JM Barros TP Meehan S Dobson CM Luheshi LM The aggregation and neurotoxicity of TDP-43 and its ALS-associated 25 kDa fragment are differentially affected by molecular chaperones in Drosophila PLoS One 2012 7 e31899 22384095 PMC3284513
  147. [163]Crippa V Carra S Rusmini P A role of small heat shock protein B8 (HspB8) in the autophagic removal of misfolded proteins responsible for neurodegenerative diseases Autophagy 2010 6 958 960 20699640
  148. [164]Hasegawa M Arai T Nonaka T Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Ann Neurol 2008 64 60 70 18546284 PMC2674108
  149. [165]Inukai Y Nonaka T Arai T Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS FEBS Lett 2008 582 2899 2904 18656473
  150. [166]Neumann M Kwong LK Lee EB Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies Acta Neuropathol 2009 117 137 149 19125255 PMC2693625
  151. [167]Kametani F Nonaka T Suzuki T Identification of casein kinase-1 phosphorylation sites on TDP-43 Biochem Biophys Res Commun 2009 382 405 409 19285963
  152. [168]Iguchi Y Katsuno M Takagi S Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies Neurobiol Dis 2012 45 862 870 22198567
  153. [169]Li HY Yeh PA Chiu HC Tang CY Tu BP Hyperphosphorylation as a defense mechanism to reduce TDP-43 aggregation PLoS One 2011 6 e23075 21850253 PMC3151276
  154. [170]Brady OA Meng P Zheng Y Mao Y Hu F Regulation of TDP-43 aggregation by phosphorylation and p62/SQSTM1 J Neurochem 2011 116 248 259 21062285
  155. [171]Choksi DK Roy B Chatterjee S TDP-43 Phosphorylation by casein kinase Iepsilon promotes oligomerization and enhances toxicity in vivo Hum Mol Genet 2014 23 1025 1035 24105464
  156. [172]Salado IG Redondo M Bello ML Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis J Med Chem 2014 57 2755 2772 24592867 PMC3969104
  157. [173]Seyfried NT Gozal YM Dammer EB Multiplex SILAC analysis of a cellular TDP-43 proteinopathy model reveals protein inclusions associated with SUMOylation and diverse polyubiquitin chains Mol Cell Proteomics 2010 9 705 718 20047951 PMC2860236
  158. [174]Hans F Fiesel FC Strong JC UBE2E ubiquitin-conjugating enzymes and ubiquitin isopeptidase Y regulate TDP-43 protein ubiquitination J Biol Chem 2014 289 19164 19179 24825905 PMC4081952
  159. [175]Wenqiang C Lonskaya I Hebron ML Parkin-mediated reduction of nuclear and soluble TDP-43 reverses behavioral decline in symptomatic mice Hum Mol Genet 2014 23 4960 4969 24847002
  160. [176]Gray DA Tsirigotis M Woulfe J Ubiquitin, proteasomes, and the aging brain Sci Aging Knowledge Environ 2003 2003 RE6 12944592
  161. [177]Majounie E Renton AE Mok K Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study Lancet Neurol 2012 11 323 330 22406228 PMC3322422

Cited by

Sorted by citations

Authors
Scotter, E. L., Chen, H.-J., & Shaw, C. E.
Venue
Neurotherapeutics
Publisher
Elsevier BV
Published
2015-04
Volume
12
Issue
2
Pages
352-363
ISSN
1878-7479
DOI
10.1007/s13311-015-0338-x
PMC
PMC4404432
Cited by
334
References
16
Language
en
Update notices
erratum (2015-04-01)
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review